Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ATP6V0E1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LOC101928162 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
TAF11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GSTM4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MBP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NKX6-1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KLRD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIER3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LSM8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STMN3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BCDIN3D-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBTF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMBIM6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BTN2A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ENTPD4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MED20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HDGFRP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CAMSAP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STAM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on